-
Vaccine Business The Gateway To Drug Stores Providing Profitable Primary Healthcare
Friday, May 19, 2017 - 9:35am | 1146Read More...In one of the stealthiest revolutions in healthcare, the role of providing vaccinations is moving away from the doctor’s office to the corner drug store and the pharmacy at your local supermarket chain, which are ultimately angling to become your primary healthcare provider. Industry giants...
-
#PreMarket Primer: Monday, December 22: White House Struggles To Respond To Sony Hack
Monday, December 22, 2014 - 10:29am | 1058Read More...The White House is struggling to find an appropriate response to the cyber attack and violent threats against Sony Corp (NYSE: SNE), which were linked to the North Korean government. Republicans in Washington have been pushing the President to enact financial sanctions against the country, but...
-
Goldman Sachs Decreases Price Target On Walgreen To $47
Wednesday, June 22, 2011 - 8:03am | 122Read More...According to Goldman Sachs, Walgreen (NYSE: WAG) price target is decreased to $47. Goldman Sachs said that WAG's underlying May quarter results exceeded our expectation, with EBIT beating our forecast in high-quality fashion, as gross margin rate exceeded our estimate despite input cost pressures...
-
Citi Reiterates 2M Rating On Walgreen
Wednesday, June 22, 2011 - 7:55am | 100Read More...According to Citi, Walgreen (NYSE: WAG) reported F3Q11 EPS of $0.65 per diluted share, above its estimate of $0.63, above consensus of $0.62, and vs. $0.52 last year (excld. one-time items LY). Citi said that reported F3Q11 EPS included a (-$0.01)/share impact from restructuring and restructuring-...
-
Goldman Sachs Previews WAG's May Quarter
Thursday, June 16, 2011 - 7:55am | 188Read More...Goldman Sachs maintains its Buy rating and its $48 price target on Walgreen Company (NYSE: WAG) as the company prepares to release its quarter results, due next Tuesday. In the report, Goldman Sachs writes, “For WAG's May quarter results, due out on June 21, we expect EPS of $0.63, vs. $0.52 a...
-
Jefferies Remains Bullish On Walgreen
Thursday, May 19, 2011 - 8:07am | 93Read More...According to Jefferies, Walgreen (NYSE: WAG) were invited to management meetings. Jefferies said that it had the opportunity to host Walgreen management in KC and Houston and came away bullish. “While industry fundamentals should support a solid Rx business, the real opportunity appears to be in...
-
Jefferies Comments On Walgreens Purchase Of Drugstore.com
Friday, March 25, 2011 - 7:17am | 181Read More...According to Jefferies, Walgreen's (NYSE: WAG) purchase of drugstore.com, while small on the relative scale, appears positive in its view as it strengthens and broadens WAG's core area of expertise and provides a foray into the fast-growing online retail channel. Jefferies reported that Walgreen...
-
Credit Suisse Lowers Estimates on Walgreen
Wednesday, March 23, 2011 - 9:20am | 37Read More...In a report published by Credit Suisse, Walgreen (NYSE: WAG) Q2 falls short of high expectations. Estimates are lowered. Rating is Neutral. Price Target is $46.00. Walgreen closed yesterday at $39.21.
-
Gabelli Increases WAG 2011 EPS Estimate
Wednesday, March 23, 2011 - 9:19am | 90Read More...Gabelli has increased Walgreen Co.'s (NYSE: WAG) 2011 EPS estimate. According to the report, "We are increasing our Fiscal 2011 EPS estimate by $0.05 to $3.60 to account for slightly higher sales and margins, net of a 40bps higher tax rate… Q2 Sales were up 8.9% to $18.5 bn. Same store sales...
-
Jefferies Sees Opportunity For WAG
Wednesday, March 23, 2011 - 8:43am | 76Read More...Jefferies has reported on the opportunities available for Walgreen Co. (NYSE: WAG). In the report Jefferies writes, "Walgreens stands to benefit from improving in-store execution and merchandising, which are clearly taking hold at retail, cost control, significant cash for share repurchases and...
-
Citi Updates WAG F2Q11 EPS Preview
Wednesday, March 16, 2011 - 7:36am | 135Read More...Citi has reported on the estimated EPS of Walgreen Co. (NYSE: WAG), which Citi had raised to $0.80. Cit writes, “We are raising our F2Q11 EPS to $0.80, up from $0.78 prev., vs. consensus of $0.80, and $0.68 LY (see Figure 1 for our assumptions). We are also raising our FY2011 estimates to $2.56,...
-
Morgan Stanley Raises WAG Target From $44 To $50.
Monday, February 28, 2011 - 10:23am | 28Read More...Morgan Stanley is raising its PT on shares of Walgreen Co. (NYSE: WAG) from $44 to $50. Walgreen Co. closed Friday at $41.97.
-
Jefferies Raises WAG PT From $45 To $48
Thursday, December 23, 2010 - 8:48am | 67Read More...Jefferies is raising its price target on Walgreen Co. (NYSE: WAG) from $45 to $48. Jefferies has also made some adjustments to its estimates for 2Q, 3Q, 4Q, FY11 and FY12 to $0.78, $0.66, $0.56, $2.62 and $3.04, respectively, from $0.77, $0.63, $0.56, $2.49 and $2.95. “The estimates largely reflect...
-
Walgreen (WAG) To Acquire Duane Reade Drugstores
Wednesday, February 17, 2010 - 9:50am | 122Read More...Drugstore chain Walgreen Co. (NYSE: WAG) announced that it had reached a deal with affiliates of Oak Hill Capital Partners to purchase Duane Reade Holdings Inc. from them for about $1.08 billion, including taking on the drugstore company's debt. Duane Reade Holdings operates 257 drugstores in the...


